Only connect: RDMD’s $14M series A provides room for better rare disease view April 16, 2020 By Randy Osborne No Comments San Francisco-based RDMD Inc. netted $14 million in series A money fueling an approach designed to generate clinical evidence that will speed drug development in rare diseases.Read More